Adbiotech

179530 · KOSDAQ · ₩179530 · 애드바이오텍

₩1,909▼ ₩74 (3.73%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩13B₩11B₩10B₩11B₩12B
Cost of sales₩7.7B₩7.1B₩7.3B₩7.5B₩6.8B
Gross profit₩5.1B₩4B₩3.2B₩3.1B₩5B
Operating income−₩3.5B−₩4.1B−₩4.8B−₩4.9B−₩1.6B
Net income−₩3.3B−₩9B−₩5.4B₩2.7B−₩2.7B
Net income to shareholders−₩3.3B−₩8B−₩2.9B₩2.7B−₩2.7B

Balance sheet

20252024202320222021
Total assets₩48B₩23B₩28B₩31B₩21B
Current assets₩21B₩8.4B₩13B₩14B₩8.7B
Cash and equivalents₩3.9B₩639M₩3B₩1.2B₩1.2B
Total liabilities₩35B₩20B₩17B₩15B₩16B
Current liabilities₩31B₩15B₩13B₩12B₩13B
Borrowings₩17B₩11B₩13B₩13B₩13B
Total equity₩14B₩3B₩11B₩16B₩5.1B
Shareholders' equity₩15B₩4.8B₩13B₩16B₩5.1B

Cash flow

20252024202320222021
Cash from operations−₩1.3B−₩4.1B₩315M−₩8.6B−₩2.2B
Capital spending₩378M₩193M₩240M₩727M₩3.6B
Free cash flow−₩1.7B−₩4.3B₩75M−₩9.3B−₩5.7B

Consolidated where available. Amounts in won.

Also known as: Adbiotech / 애드바이오텍 / 179530 / KRX:179530

Source: KRX statistical information